The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
NO‐ and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle
Open accessAbstract
Soluble guanylyl cyclase (sGC) is the only proven receptor for the ubiquitous biological messenger nitric oxide (NO) and is intimately involved in many signal transduction pathways, most notably in regulating vascular tone and platelet function. sGC is a heterodimeric (α/ß) protein that converts GTP to cyclic GMP; NO binds to its prosthetic haem group. Here, we report the discovery of a novel sGC activating compound, its interaction with a previously unrecognized regulatory site and its therapeutic implications. Through a high‐throughput screen we identified BAY 58‐2667, an amino dicarboxylic acid which potently activates sGC in an NO‐independent manner. In contrast to NO, YC‐1 and BAY 41‐2272, the sGC stimulators described recently, BAY 58‐2667 activates the enzyme even after it has been oxidized by the sGC inhibitor ODQ or rendered haem deficient. Binding studies with radiolabelled BAY 58‐2667 show a high affinity site on the enzyme. Using photoaffinity labelling studies we identified the amino acids 371 (α‐subunit) and 231 – 310 (ß‐subunit) as target regions for BAY 58‐2667. sGC activation by BAY 58‐2667 results in an antiplatelet activity both in vitro and in vivo and a potent vasorelaxation which is not influenced by nitrate tolerance. BAY 58‐2667 shows a potent antihypertensive effect in conscious spontaneously hypertensive rats. In anaesthetized dogs the hemodynamic effects of BAY 58‐2667 and GTN are very similar on the arterial and venous system. This novel type of sGC activator is a valuable research tool and may offer a new approach for treating cardiovascular diseases. British Journal of Pharmacology (2002) 136, 773–783; doi:10.1038/sj.bjp.0704778
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
High resolution two-dimensional electrophoresis of proteins.
O'Farrell, P. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41496-8 · Cited by 19,246
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Garthwaite, J., Southam, E., Boulton, C. L., Nielsen, E. B., Schmidt, K., & Mayer, B. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10233-2 · Cited by 1,101
Crystal Structure of the Catalytic Domains of Adenylyl Cyclase in a Complex with G sα ·GTPγS
Tesmer, J. J. G., Sunahara, R. K., Gilman, A. G., & Sprang, S. R. (1997) · Science · doi:10.1126/science.278.5345.1907 · Cited by 796
NO-independent regulatory site on soluble guanylate cyclase
Stasch, J.-P., Becker, E. M., Alonso-Alija, C., Apeler, H., Dembowsky, K., Feurer, A., Gerzer, R., Minuth, T., Perzborn, E., Pleiß, U., et al. (2001) · Nature · doi:10.1038/35065611 · Cited by 545
Self-citationYC-1, a novel activator of platelet guanylate cyclase
Ko, F., Wu, C., Kuo, S., Lee, F., & Teng, C. (1994) · Blood · doi:10.1182/blood.v84.12.4226.bloodjournal84124226 · Cited by 402
Murad, F. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990712)38:13/14<1856::aid-anie1856>3.0.co;2-d · Cited by 381
Nitric Oxide: A Unique Endogenous Signaling Molecule in Vascular Biology (Nobel Lecture)
Ignarro, L. J. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990712)38:13/14<1882::aid-anie1882>3.0.co;2-v · Cited by 362
Schrammel, A., Behrends, S., Schmidt, K., Koesling, D., & Mayer, B. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09113-8 · Cited by 360
Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme.
Friebe, A., Schultz, G., & Koesling, D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01078.x · Cited by 352
The use of nitric oxide donors in pharmacological studies
Feelisch, M. (1998) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005231 · Cited by 347
Furchgott, R. F. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990712)38:13/14<1870::aid-anie1870>3.0.co;2-8 · Cited by 334
Münzel, T., Kurz, S., Rajagopalan, S., Thoenes, M., Berrington, W. R., Thompson, J. A., Freeman, B. A., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118935 · Cited by 314
Inhibition of Soluble Guanylate Cyclase by ODQ
Zhao, Y., Brandish, P. E., DiValentin, M., Schelvis, J. P. M., Babcock, G. T., & Marletta, M. A. (2000) · Biochemistry · doi:10.1021/bi9929296 · Cited by 234
Mülsch, A., Bauersachs, J., Schäfer, A., Stasch, J., Kast, R., & Busse, R. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700982 · Cited by 222
Self-citationWu, C., Ko, F., Kuo, S., Lee, F., & Teng, C. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16400.x · Cited by 197
Zhao, Y., Schelvis, J. P. M., Babcock, G. T., & Marletta, M. A. (1998) · Biochemistry · doi:10.1021/bi972686m · Cited by 161
Elkayam, U. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-8-667 · Cited by 156
NO-Independent stimulators of soluble guanylate cyclase
Straub, A., Stasch, J., Alonso‐Alija, C., Benet‐Buchholz, J., Ducke, B., Feurer, A., & Fürstner, C. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00073-7 · Cited by 149
Self-citationMülsch, A., Oelze, M. W., Klöss, S., Mollnau, H., Töpfer, A., Smolenski, A., Walter, U., Stasch, J., Warnholtz, A., Hink, U., et al. (2001) · Circulation · doi:10.1161/01.cir.103.17.2188 · Cited by 134
Self-citationStasch, J., Alonso‐Alija, C., Apeler, H., Dembowsky, K., Feurer, A., Minuth, T., Perzborn, E., Schramm, M., & Straub, A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704484 · Cited by 132
Self-citationStasch, J., Dembowsky, K., Perzborn, E., Stahl, E., & Schramm, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704483 · Cited by 120
Self-citationHoenicka, M., Becker, E., Apeler, H., Sirichoke, T., Schröder, H., Gerzer, R., & Stasch, J. (1999) · Journal of Molecular Medicine · doi:10.1007/s001090050292 · Cited by 112
Self-citationTeng, C., Wu, C., Ko, F., Lee, F., & Kuo, S. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00911-9 · Cited by 85
Martin, E., Lee, Y., & Murad, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231486198 · Cited by 80
NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272
Becker, E. M., Alonso‐Alija, C., Apeler, H., Gerzer, R., Minuth, T., Pleiβ, U., Schmidt, P. M., Schramm, M., Schröder, H., Schroeder, W., et al. (2001) · BMC Pharmacology · doi:10.1186/1471-2210-1-13 · Cited by 66
Self-citationBecker, E. M., Schmidt, P. M., Schramm, M., Schröder, H., Walter, U., Hoenicka, M., Gerzer, R., & Stasch, J. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200003000-00007 · Cited by 34
Self-citationHobbs, A. J. (2000) · Emerging Therapeutic Targets · doi:10.1517/14728222.4.6.735 · Cited by 32
Soluble Guanylate Cyclase: Effect of YC-1 on Ligation Kinetics with Carbon Monoxide
Sharma, V. S., Magde, D., Kharitonov, V. G., & Koesling, D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9812 · Cited by 26
Generation and Characterization of a Stable Soluble Guanylate Cyclase-Overexpressing CHO Cell Line
Becker, E. M., Wunder, F., Kast, R., Robyr, C., Hoenicka, M., Gerzer, R., Schröder, H., & Stasch, J. (1999) · Nitric Oxide · doi:10.1006/niox.1999.0207 · Cited by 21
Self-citationEnzymology of Soluble Guanylyl Cyclase
Koesling, D., & Friebe, A. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57077-3_5 · Cited by 11
Cited by
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
Francis, S. H., Busch, J. L., & Corbin, J. D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002907 · Cited by 1,028
Concepts of neural nitric oxide‐mediated transmission
Garthwaite, J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06285.x · Cited by 807
Nitric oxide signalling in cardiovascular health and disease
Farah, C., Michel, L. Y. M., & Balligand, J.-L. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.224 · Cited by 779
Evgenov, O. V., Pacher, P., Schmidt, P. M., Haskó, G., Schmidt, H. H. H. W., & Stasch, J.-P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2038 · Cited by 749
Self-citationPulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Metadata
- Authors
- Stasch, J., Schmidt, P., Alonso‐Alija, C., Apeler, H., Dembowsky, K., Haerter, M., Heil, M., Minuth, T., Perzborn, E., Pleiss, U., Schramm, M., Schroeder, W., Schröder, H., Stahl, E., Steinke, W., & Wunder, F.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2002-07
- Volume
- 136
- Issue
- 5
- Pages
- 773-783
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2003913161
- Cited by
- 313
- References
- 33
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.